본문 바로가기 주 메뉴 바로가기

IR

  1. Home
  2. IR
  3. Shareholders
STOCKHOLDER STATUS
This is the news about Arche Investment’s shareholders.

(Unit: 1 mn KRW, %, shares)

Shareholders
Name Amount Portion Number of Shares
REYON 10,000 100.0 2,000,000
Total 10,000 100.0 2,000,000
REYON PHARMACEUTICAL Co.,Ltd. (listed company)

REYON PHARMACEUTICAL Co.,Ltd. has been specialized in producing and selling pharmaceuticals and pharmaceutical ingredients since 1964. The revenues are generated by generic pharmaceuticals, original pharmaceuticals, and pharmaceutical ingredients. Generic pharmaceuticals consist of various drugs for antibiotics, circulatory systems, and liquid formulas and each category is making even contribution to revenues.

In terms of original pharmaceuticals, we are concentrating on Optiray which is the contrast media for CT and we have exclusive supply rights in Korea with long-term agreements with ISK (Imaging Solutions Korea Ltd., formerly Mallinckrodt Korea Inc.). Pharmaceutical ingredients generally include streptokinaseㆍstreptodornase ("SKD"), Arbekacin sulfate ("ABK"), and Teicoplanin.